Skip to search.
 TSX Down 0.55% TSX Ventures Down 1.35%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
2.47 Down 0.04(1.59%) May 4, 3:57PM EDT
Prev Close:2.51
Open:2.42
Bid:N/A
Ask:3.84 x 1000
1y Target Est:12.80
Beta:1.22783
Earnings Date:May 10 - May 16 (Est.)
Day's Range:2.41 - 2.57
52wk Range:1.69 - 5.84
Volume:8,042
Avg Vol (3m):37,140
Market Cap:17.25M
P/E (ttm):N/A
EPS (ttm):-2.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXADown 1.59%17.25M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.05
Quarterly EPS Est (Mar-16) :-0.35
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback